摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-formylimidazo[1,2-a]pyridine-6-carbonitrile | 1019019-92-1

中文名称
——
中文别名
——
英文名称
3-formylimidazo[1,2-a]pyridine-6-carbonitrile
英文别名
——
3-formylimidazo[1,2-a]pyridine-6-carbonitrile化学式
CAS
1019019-92-1
化学式
C9H5N3O
mdl
MFCD09994345
分子量
171.158
InChiKey
YSLAWDMCNJBCGA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.31±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    58.2
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    3-formylimidazo[1,2-a]pyridine-6-carbonitrile 在 sodium hydride 、 溶剂黄146 作用下, 以 四氢呋喃甲醇N,N-二甲基甲酰胺 为溶剂, 反应 4.0h, 生成
    参考文献:
    名称:
    Design, synthesis and biological evaluation of acylhydrazone derivatives as PI3K inhibitors
    摘要:
    Since the PI3K signaling pathway is the most commonly activated in human cancers, inhibition of PI3K K is a promising approach to cancer therapy. In this study, a series of 2-methyl-5-nitrobenzeneacylhydrazones were designed and synthesized. All the new derivatives were tested by p110 alpha enzymatic and Rh30 cellular assays. Further enzyme selectivity profiling proved that 6e and 7 were potential selective P13K inhibitors. (C) 2014 Ling-Hua Meng and Wen-Hu Duan. Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. All rights reserved.
    DOI:
    10.1016/j.cclet.2014.10.016
  • 作为产物:
    描述:
    2-氨基-5-氰基吡啶2-溴丙二醛乙醇 为溶剂, 反应 0.17h, 以73%的产率得到3-formylimidazo[1,2-a]pyridine-6-carbonitrile
    参考文献:
    名称:
    微波辅助合成3-甲酰基取代的咪唑并[1,2- a ]吡啶
    摘要:
    一种高效,无金属的3-甲酰基咪唑合成方法[1,2- 据报道有]吡啶。该方法利用可商购的基材,并且具有广泛的基材范围。分离了中间体烯胺,并提出了合理的反应机理。
    DOI:
    10.1016/j.tetlet.2019.151244
点击查看最新优质反应信息

文献信息

  • Functionalization of the imidazo[1,2-<i>a</i>]pyridine ring in α-phosphonoacrylates and α-phosphonopropionates via microwave-assisted Mizoroki–Heck reaction
    作者:Damian Kusy、Agata Wojciechowska、Joanna Małolepsza、Katarzyna M Błażewska
    DOI:10.3762/bjoc.16.3
    日期:——
    A series of new phosphonocarboxylates containing an imidazo[1,2-a]pyridine ring has been synthesized via the microwave-assisted Mizoroki-Heck reaction. The efficient modification of the imidazo[1,2-a]pyridine ring has been achieved as late-stage functionalization, enabling and accelerating the generation of a library of compounds from a common precursor.
    通过微波辅助的Mizoroki-Heck反应合成了一系列含有咪唑并[1,2-a]吡啶环的新膦酰基羧酸酯。咪唑并[1,2-a]吡啶环的有效修饰已作为后期功能化而实现,从而能够并加速从常见前体生成化合物库。
  • Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110α inhibitors
    作者:Masahiko Hayakawa、Ken-ichi Kawaguchi、Hiroyuki Kaizawa、Tomonobu Koizumi、Takahide Ohishi、Mayumi Yamano、Minoru Okada、Mitsuaki Ohta、Shin-ichi Tsukamoto、Florence I. Raynaud
    DOI:10.1016/j.bmc.2007.05.070
    日期:2007.9.1
    We have previously reported the imidazo[1,2-a]pyridine derivative 4 as a novel p110 alpha inhibitor; however, although 4 is a potent inhibitor of p110 alpha enzymatic activity and tumor cell proliferation in vitro, it is unstable in solution and ineffective in vivo. To increase stability the pyrazole of 4 was replaced with a hydrazone and a moderately potent p110 alpha inhibitor 7a was obtained. Subsequent optimization of 7a afforded exceptionally potent p110 alpha inhibitors, including 8c and 8h, with IC(50) values of 0.30 nM and 0.26 nM, respectively; to the best of our knowledge, these compounds are the most potent PI3K p110 alpha inhibitors reported to date. Compound 8c was also stable in solution and exhibited significant anti-tumor effectiveness in vivo. (c) 2007 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

阿法拉定A,TFA 钠咪唑并[1,2-a]吡啶-2-羧酸酯水合物(1:1:1) 钠(E)-2-氰基-3-[2,8-二(丙-2-基氧基)咪唑并[3,2-a]吡啶-3-基]丙-2-烯酸酯 诺白拉斯啶 苯酚,4-(5,6,7,8-四氢咪唑并[1,2-a]吡啶-8-基)- 米诺膦酸 米诺磷酸一水合物 硫酸利美戈潘 盐酸法屈唑半水合物 盐酸依格列汀 甲基咪唑并[1,5-A]吡啶-1-甲酸叔丁酯 甲基3-氨基咪唑并[1,2-a]吡啶-5-羧酸酯 甲基-(7-甲基咪唑并[1,2-A〕吡啶-2-基甲基)-胺 甲基-(5-甲基-咪唑并[1,2-A]吡啶-2-甲基)-胺 甲基 2-甲基咪唑并[1,2-a]吡啶-3-羧酸 环戊烷羧酸2-氨基-4-亚甲基-,(1R,2S)-(9CI) 环巴胺抑制剂1 泰妥拉唑 法倔唑盐酸盐 法倔唑 沃利替尼(对映异构体) 沃利替尼 氨基膦酸杂质14 戊酰胺,N-(2-丁基-1H-咪唑并[4,5-b]吡啶-6-基)- 巴马鲁唑 奥克塞米索 地扎胍宁甲磺酸盐 地扎胍宁 土大黄甙 咪唑磺隆 咪唑并吡啶-6-甲胺盐酸盐 咪唑并吡啶-2-酮盐酸盐 咪唑并吡啶-2-酮 咪唑并二甲基吡啶 咪唑并[2,1-a]异喹啉-2(3H)-酮 咪唑并[1,5-a]喹唑啉,6-氯-3-(3-环丙基-1,2,4-噁二唑-5-基)-5-(4-吗啉基)- 咪唑并[1,5-a]吡啶-8-胺 咪唑并[1,5-a]吡啶-8-羧酸乙酯 咪唑并[1,5-a]吡啶-8-甲醛 咪唑并[1,5-a]吡啶-7-羧酸甲酯 咪唑并[1,5-a]吡啶-7-羧酸乙酯 咪唑并[1,5-a]吡啶-6-羧酸甲酯 咪唑并[1,5-a]吡啶-6-羧酸乙酯 咪唑并[1,5-a]吡啶-5-胺 咪唑并[1,5-a]吡啶-5-羧酸甲酯 咪唑并[1,5-a]吡啶-5-羧酸乙酯 咪唑并[1,5-a]吡啶-5-甲醛 咪唑并[1,5-a]吡啶-3-羧酸乙酯 咪唑并[1,5-a]吡啶-3-磺酰胺 咪唑并[1,5-a]吡啶-3-甲醛